T1	Participants 13 47	advanced hepatocellular carcinoma:
T2	Participants 91 114	French clinical trials.
T3	Participants 217 259	Cancer of the Liver Italian Program (CLIP)
T4	Participants 264 307	Barcelona Clinic Liver Cancer group (BCLC)]
T5	Participants 336 380	patients with hepatocellular carcinoma (HCC)
T6	Participants 443 511	French patients with HCC whose main etiology is alcoholic cirrhosis.
T7	Participants 520 650	We have pooled two randomized clinical trials in palliative condition from the Fédération Francophone de Cancerologie Digestive.
T8	Participants 651 689	They had included 416 and 122 patients
T9	Participants 1071 1092	included 538 patients
